2nd Gene Therapy Analytical Development Summit
Evvnt Promotion / evvnt
Archivio
30.11.2020 - 03.12.2020 Online
Time: 10:00 to 18:00
Temi della conferenza
In the context of rapid gene therapy progress and mounting regulatory scrutiny, the 2nd Annual Gene Therapy Analytical Development Summit will unite virtually large pharma and innovative biotechs to discuss the full and comprehensive range of analytical tools required to guarantee the consistency, quality and safety of gene therapy products.
In the context of rapid gene therapy progress and mounting regulatory scrutiny, the 2nd Annual Gene Therapy Analytical Development Summit will unite virtually large pharma and innovative biotechs to discuss the full and comprehensive range of analytical tools required to guarantee the consistency, quality and safety of gene therapy products.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Sponsor: https://go.evvnt.com/663255-3?pid=4832
Speakers: Yuan Zhao, Leader of Gene Therapy Section, Advanced Therapy Division/NIBSC, MHRA, Claire Davies, Head of Bioanalytics, Sanofi, and more.
Sponsor: https://go.evvnt.com/663255-3?pid=4832
Speakers: Yuan Zhao, Leader of Gene Therapy Section, Advanced Therapy Division/NIBSC, MHRA, Claire Davies, Head of Bioanalytics, Sanofi, and more.
Informazioni ed Iscrizioni:
https://go.evvnt.com/663255-2?pid=4832
Ms. Marketing Manager Olivia Bull
Medicina General
Lingua
Inglese
Inglese
Quote del Congresso
USD 1749.00 to USD 3585.00
USD 1749.00 to USD 3585.00
I partecipanti attesi
500 - 500
500 - 500
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
